« Back
Home /
C8 Galactosylceramide (d18:1/8:0)

C8 Galactosylceramide (d18:1/8:0)

Item no.	TMO-T36323-10mg
Manufacturer	TargetMol
CASRN	41613-16-5
Amount	10mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	0,98
Smiles	O(C[C@H](NC(CCCCCCC)=O)[C@@H](/C=C/CCCCCCCCCCCCC)O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Short Description	C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated into the nanoliposomal membrane of nanoliposomal-doxorubicin. C8 Galactosylceramide induces proliferation and cytokine production by splenocytes in vitro at concentrations ranging from 100-1, 000 ng/ml but has no effect on natural killer T cell production in vivo. It also activates NF-κB production in C6 glioma cells when used at a concentration of 10 μM.
Shipping	cool pack
Storage	-20°
Molecular Weight	587, 83

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail